Home/Browse by collection/Immune Cell Therapies and Immune Cell Engineering

Immune Cell Therapies and Immune Cell Engineering

Section Edited by Marcela V. Maus, MD, PhD Immune cell therapies and cell engineering approaches, new targets, novel functionalities, clinical trial results, correlative studies in patients who have received cell-based therapies, novel engineering strategies (molecular switches, conditional expression, logic gating), gene-edited cells to knock out or knock in novel functions, synthetic gene circuits. Includes pre-clinical animal modeling (small and large) and clinical trials.

Showing results 71 - 80 of 100

Sorted by most recent

Automated, scaled, transposon-based production of CAR T cells
Dominik Lock, Razieh Monjezi, Caroline Brandes, Stephan Bates, Simon Lennartz, Karin Teppert, Leon Gehrke, Rafailla Karasakalidou-Seidt, Teodora Lukic, Marco Schmeer, Martin Schleef, Niels Werchau, Matthias Eyrich, Mario Assenmacher, Andrew KaiserSee the full list of authors

12 September 2022